跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MYLAN-VERAPAMIL SR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MYLAN-VERAPAMIL SR
Authorized
STANDARD
MYLAN-VERAPAMIL SR
Mylan Pharmaceuticals ULC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
250bcc56e1ea0c1c
Company
Mylan Pharmaceuticals ULC
Type
Standard
Approval Details
Approval Id
250bcc56e1ea0c1c
Drug Approval Canada Name
MYLAN-VERAPAMIL SR
Product Name
MYLAN-VERAPAMIL SR
Status
Dormant
Status Date
2024-03-11
Original Market Date
2016-09-01
Din
02450496
Drug Class
Human
Dosage Form
Tablet (Extended-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:28.92
Atc Original
C08DA01 VERAPAMIL
Atc Name
c 08 da 01
Aig Number
0113846003
Company Name
Mylan Pharmaceuticals ULC
Company Address
85 Advance Road, Etobicoke, Ontario, Canada, M8Z 2S6
Active Ingredients
VERAPAMIL HYDROCHLORIDE
240 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
250bcc56e1ea0c1c
Type
Standard
Back to Health Canada Approvals